Doug Gessl
Directeur Financier/CFO chez Ception Therapeutics, Inc.
Profil
Doug Gessl is currently the Chief Financial Officer at Ception Therapeutics, Inc. Prior to this, he held positions as Principal at Tucker Anthony Sutro and Nesbitt Burns, Inc., Principal at JPMorgan Chase & Co., Vice President-Finance & Administration at Fulcrum Pharmaceuticals, Inc., Chief Operating & Financial Officer at Ceptaris Therapeutics, Inc., and Senior Vice President at Einhorn Associates, Inc. Gessl holds an MBA from The University of Chicago and an undergraduate degree from the University of Wisconsin.
Postes actifs de Doug Gessl
| Sociétés | Poste | Début |
|---|---|---|
Ception Therapeutics, Inc.
 Ception Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ception Therapeutics, Inc. Develops pharmaceutical products. It focuses on the discovery and development of novel products to address areas of unmet medical need. The company was founded in 2004 and is headquartered in Malvern, PA. | Directeur Financier/CFO | - |
Anciens postes connus de Doug Gessl
| Sociétés | Poste | Fin |
|---|---|---|
Ceptaris Therapeutics, Inc.
 Ceptaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ceptaris Therapeutics, Inc. develops mechlorethamine gels. The firm develops a gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma. The company was founded in 2002 and is headquartered in Malvern, PA. | Directeur Financier/CFO | - |
| JPMORGAN CHASE & CO. | Corporate Officer/Principal | - |
| Nesbitt Burns, Inc. | Corporate Officer/Principal | - |
| Tucker Anthony Sutro | Corporate Officer/Principal | - |
| Einhorn Associates, Inc. | Corporate Officer/Principal | - |
Formation de Doug Gessl
| The University of Chicago | Masters Business Admin |
| University of Wisconsin | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| JPMORGAN CHASE & CO. | Finance |
| Entreprise privées | 6 |
|---|---|
Ception Therapeutics, Inc.
Ception Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ception Therapeutics, Inc. Develops pharmaceutical products. It focuses on the discovery and development of novel products to address areas of unmet medical need. The company was founded in 2004 and is headquartered in Malvern, PA. | Health Technology |
| Fulcrum Pharmaceuticals, Inc. | Health Technology |
| Einhorn Associates, Inc. | Finance |
| Tucker Anthony Sutro | Finance |
| Nesbitt Burns, Inc. | Finance |
Ceptaris Therapeutics, Inc.
Ceptaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ceptaris Therapeutics, Inc. develops mechlorethamine gels. The firm develops a gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma. The company was founded in 2002 and is headquartered in Malvern, PA. | Health Technology |
